Who makes Diltiazem Oral Product?

Diltiazem Oral Product is developed by Virginia Commonwealth University.

What development phase is Diltiazem Oral Product in?

Diltiazem Oral Product is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Diltiazem Oral Product

Virginia Commonwealth University · FDA-approved active Small molecule Quality 5/100

At a glance

Generic name	Diltiazem Oral Product
Sponsor	Virginia Commonwealth University
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Flecainide Safety in Patients With Coronary Artery Disease and Atrial Fibrillation (PHASE4)
Efficacy of Medical Therapy in Women and Men With Angina and Myocardial Bridging (PHASE2)
Effect of Oral and Intravenous Diltiazem Protocol for Emergency Department Atrial Fibrillation (PHASE4)
A Drug-Drug Interaction Study of Diltiazem and MK-1167 in Healthy Adult Participants (MK-1167-006) (PHASE1)
A Drug-Drug Interaction Study of Diltiazem and MK-5684 in Healthy Adult Male Participants (MK-5684-011) (PHASE1)
Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial). (PHASE4)
Oral vs Intravenous Diltiazem for Rapid Atrial Fibrillation/Flutter Trial (PHASE4)
Heart Rate Controller in Computed Tomography Coronary Angiography (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Diltiazem Oral Product CI brief — competitive landscape report
Diltiazem Oral Product updates RSS · CI watch RSS
Virginia Commonwealth University portfolio CI